Results 101 to 110 of about 16,265,183 (153)

Development and Validation of a Machine Learning Model to Predict Oral Anticoagulant Use in Stroke From Prothrombin Time-International Normalized Ratio and Activated Partial Thromboplastin Time. [PDF]

J Am Heart Assoc
Fujiwara G, Nagakane Y, Murakami N, Suehiro E, Hashimoto N, Yoshimura S, Toyoda K, Okada Y.   +7 more
europepmc   +1 more source

Identifying the silent deficiency: Severe Factor XI deficiency in an asymptomatic patient with isolated prolonged activated partial thromboplastin time-A case report. [PDF]

SAGE Open Med Case Rep
Alshurafa A, Draidi M, Ibrahim F, Mohamed SF, Yassin MA.   +4 more
europepmc   +1 more source

Reagent Effects on the Activated Partial Thromboplastin Time Clot Waveform Analysis: A Multi-Centre Study. [PDF]

Diagnostics (Basel), 2023
Wong WH, Tan CW, Abdul Khalid NB, Dalimoenthe NZ, Yip C, Tantanate C, Lim RD, Kim JH, Ng HJ.   +8 more
europepmc   +1 more source

Diagnostic Performance of Prothrombin Time and Activated Partial Thromboplastin Time in Children: A Service Evaluation. [PDF]

Int J Lab Hematol
Gurumurthy G, Lemma M, Reynolds L, Grainger J, Thachil J.   +4 more
europepmc   +1 more source

International normalized ratio and activated partial thromboplastin time testing. [PDF]

CMAJ, 2022
Chornenki NLJ, Fralick M, Sholzberg M.
europepmc   +1 more source

Laboratory Identification of Lupus Anticoagulant (LA) Using Different Activated Partial Thromboplastin Time (APTT) Assays. [PDF]

Int J Lab Hematol
Barion BG, Stefanello B, de Paula MLSA, Saraiva TS, Villaça PR, Rocha V, Orsi FA, da Rocha TRF.   +7 more
europepmc   +1 more source

Comparative analysis on characteristics of two activated partial thromboplastin time reagents. [PDF]

J Clin Lab Anal, 2022
Yasui Y, Ishii T, Tatebe J, Morita T.
europepmc   +1 more source

Survey of clot waveform analysis of normal activated partial thromboplastin time in patients with cirrhosis and sepsis at Le Van Thinh hospital. [PDF]

PLoS One
Phuong Linh TQ, Nhan NT, Thuan LM, Phuong LT.   +3 more
europepmc   +1 more source

Activated partial thromboplastin time prolongation without hemorrhagic dienhesis: a study of a chinese family coexisting with hereditary KNG1 p.Arg240 mutation and --SEA/αα genotype thalassemia. [PDF]

Ann Hematol
Bai Z, Hu J, Jin Y, Li X, Sun J, Zhang F, Wu D, Zhao F, Ji P.   +8 more
europepmc   +1 more source

Impact of Heparin Hemodialysis Catheter Lock on Partial Thromboplastin Time Assays in Inpatients on Therapeutic Intravenous Heparin. [PDF]

Semin Dial
Tuggle TS, Noureddine L, Hobbs RA.
europepmc   +1 more source